Access to Breast Cancer Diagnosis Act of 2019
United States116th CongressHR-2428House of Representatives
Updated: May 2, 2019
Summary
Access to Breast Cancer Diagnosis Act of 2019 This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-3216: Access to Breast Cancer Diagnosis Act of 2020Introduced in Senate
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.